Articles Tagged With:
-
Early Hot Flashes Could Signal Increased Risk for Heart Disease
Women 42-55 years of age who experience hot flashes are more likely to exhibit poor vascular function.
-
FDA Actions
In this section: New FDA commissioner off to fast start on opioids, drug safety, and orphan drug designation.
-
Comparing Insulin Treatments for Diabetic Patients
Authors of two studies suggested that 32 weeks’ treatment with insulin degludec vs. insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemic episodes.
-
Exploring the Rising Prices of Generic Drugs
Study: As competition among generic drugs decreases, prices go up.
-
Investigators Tackle Antimicrobial Resistance
Researchers suggested that “modified use of antimicrobial agents and public health interventions, coupled with novel antimicrobial strategies, may help mitigate the effect of multidrug-resistant organisms in the future.”
-
Antibiotics for Upper Respiratory Infections in Elderly Patients
Physicians who were more likely to prescribe an antibiotic for an acute upper respiratory tract infection included mid- and late-career physicians, physicians trained outside of Canada or the United States, and high-volume physicians.
-
New PPI Mortality Data: Is There a Risk?
Are proton pump inhibitors associated with excess risk of mortality? That is the finding of a highly publicized study.
-
The Epidemiology of Violence: Knowledge Is Power
As hospital violence has become a national issue and the subject of a possible federal regulation, researchers are showing that interventions using the basic epidemiologic principles of measurement and feedback can reduce unit-level violence by patients against healthcare workers.
-
Making the Business Case for Safe Patient Handling
Employee health professionals can convince administration that safe patient handling equipment is a good investment if they show how an increasingly immobile patient population affects the physical health of the worker and the fiscal health of the hospital.
-
WHO Ready to Use Ebola Vaccine in Congo
The World Health Organization is poised to begin vaccinating healthcare workers with an experimental new Ebola vaccine, but continues to hold off as an outbreak in the Democratic Republic of the Congo appeared to be dissipating as this report was filed.